Journal
INTERNATIONAL IMMUNOLOGY
Volume 18, Issue 1, Pages 11-18Publisher
OXFORD UNIV PRESS
DOI: 10.1093/intimm/dxh337
Keywords
hepatitis C; IFN-gamma; natural immunity; gamma delta T cells
Categories
Ask authors/readers for more resources
Hepatitis C virus (HCV) has evolved complex strategies to evade host immune responses and establish chronic infection. Since human V gamma 9V delta 2 T lymphocytes play a critical role in the immune response against viruses, we analyzed their antiviral functions on Huh7 hepatoma cells carrying the subgenomic HCV replicon (Rep60 cells). In a transwell culture system, Rep60 cells were co-cultured with either PBMCs or highly purified gamma delta T cells stimulated by non-peptidic antigens. V gamma 9V delta 2 T cell activation was associated with a dramatic reduction of HCV RNA levels. Neutralizing antibodies targeting IFN-gamma revealed a critical role for this cytokine in the inhibition of HCV replication. Interestingly, drugs already in clinical use, such as Phosphostim and Zoledronate, known to activate gamma delta T cells, were shown to induce the inhibition of HCV replication mediated by V gamma 9V delta 2 T cells of HCV patients. Our data suggest that the therapeutic activation of V gamma 9V delta 2 T lymphocytes may represent an additional strategy to inhibit HCV replication and to restore a T(h)1-oriented immune response in HCV-infected patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available